145 related articles for article (PubMed ID: 3524819)
1. Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.
Theillet C; Lidereau R; Escot C; Hutzell P; Brunet M; Gest J; Schlom J; Callahan R
Cancer Res; 1986 Sep; 46(9):4776-81. PubMed ID: 3524819
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
3. Activated H-ras oncogenes in human kidney tumors.
Fujita J; Kraus MH; Onoue H; Srivastava SK; Ebi Y; Kitamura Y; Rhim JS
Cancer Res; 1988 Sep; 48(18):5251-5. PubMed ID: 2457438
[TBL] [Abstract][Full Text] [Related]
4. ras oncogene activation in human ovarian carcinoma.
van 't Veer LJ; Hermens R; van den Berg-Bakker LA; Cheng NC; Fleuren GJ; Bos JL; Cleton FJ; Schrier PI
Oncogene; 1988 Feb; 2(2):157-65. PubMed ID: 3285294
[TBL] [Abstract][Full Text] [Related]
5. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA
Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785
[TBL] [Abstract][Full Text] [Related]
6. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE
Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
[TBL] [Abstract][Full Text] [Related]
7. Specific H-Ras minisatellite alleles in breast cancer susceptibility.
Gosse-Brun S; Sauvaigo S; Daver A; Page M; Lortholary A; Larra F; Bignon YJ; Bernard-Gallon D
Anticancer Res; 1999; 19(6B):5191-6. PubMed ID: 10697533
[TBL] [Abstract][Full Text] [Related]
8. ras mutations and expression in head and neck squamous cell carcinomas.
Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
[TBL] [Abstract][Full Text] [Related]
9. c-Ha-ras-1 polymorphism in human breast carcinomas: evidence for a normal distribution of alleles.
Sheng ZM; Guerin M; Gabillot M; Spielmann M; Riou G
Oncogene Res; 1988 Feb; 2(3):245-50. PubMed ID: 2897104
[TBL] [Abstract][Full Text] [Related]
10. c-K-ras mutations in human carcinomas occur preferentially in codon 12.
Yanez L; Groffen J; Valenzuela DM
Oncogene; 1987; 1(3):315-8. PubMed ID: 3330777
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the estrogen receptor gene structure in human breast cancer.
Koh EH; Ro J; Wildrick DM; Hortobagyi GN; Blick M
Anticancer Res; 1989; 9(6):1841-5. PubMed ID: 2576351
[TBL] [Abstract][Full Text] [Related]
13. [Joint amplification of c-myc and c-Ha-ras oncogenes in human breast and thyroid cancer cells].
Pluzhnikova GF; Serova OM; Kniazev PG; Fedorov SN; Novikov LB
Eksp Onkol; 1987; 9(2):15-7. PubMed ID: 3034547
[TBL] [Abstract][Full Text] [Related]
14. Activation of the K-ras protooncogene in lung tumors from rats and mice chronically exposed to tetranitromethane.
Stowers SJ; Glover PL; Reynolds SH; Boone LR; Maronpot RR; Anderson MW
Cancer Res; 1987 Jun; 47(12):3212-9. PubMed ID: 3581065
[TBL] [Abstract][Full Text] [Related]
15. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.
Park JB; Rhim JS; Park SC; Kimm SW; Kraus MH
Cancer Res; 1989 Dec; 49(23):6605-9. PubMed ID: 2573419
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
Pechoux C; Chardonnet Y; Chignol MC; Noël P
Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer.
Bièche I; Lidereau R
Mol Carcinog; 2000 Nov; 29(3):151-8. PubMed ID: 11108660
[TBL] [Abstract][Full Text] [Related]
18. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
19. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
Naidu R; Wahab NA; Yadav M; Kutty MK
Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
[TBL] [Abstract][Full Text] [Related]
20. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers.
Riou G; Barrois M; Sheng ZM; Duvillard P; Lhomme C
Oncogene; 1988 Sep; 3(3):329-33. PubMed ID: 3060795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
